LIVASTEP-M KID Tablet is a specially formulated pediatric anti-allergic combination designed for effective management of allergic rhinitis, seasonal allergies, allergic cough, sneezing, nasal congestion, and bronchial hypersensitivity in children.

This advanced dual-action formula combines:

• Levocetirizine 2.5 mg – A third-generation antihistamine that blocks H1 receptors to reduce sneezing, itching, runny nose, and watery eyes with minimal sedation.

• Montelukast 4 mg – A leukotriene receptor antagonist that reduces airway inflammation, prevents bronchoconstriction, and controls allergic triggers at the respiratory level.

Together, they provide comprehensive control over pediatric allergic conditions by targeting both histamine-mediated and leukotriene-mediated pathways.

🔷 Therapeutic Benefits

• Effective relief from seasonal & perennial allergic rhinitis

• Controls dust, pollen & environmental allergies

• Reduces allergic cough and throat irritation

• Supports management of mild bronchial asthma associated with allergy

• Improves breathing comfort and sleep quality in children

The balanced pediatric dosage ensures optimal efficacy with good tolerability, making it a preferred choice for long-term allergy management in children.

🔷 Clinical Advantages

✔ Dual mechanism of action
✔ Minimal drowsiness
✔ Once-daily dosing for better compliance
✔ Suitable for pediatric allergy management
✔ Strong prescription demand in pediatric segment

Marketed by Varmed Pharma Pvt Ltd, a trusted and growing name in the PCD Pharma Franchise industry, LIVASTEP-M KID is a high-potential brand in the pediatric and anti-allergic range. It offers excellent business opportunities under the PCD Pharma Franchise / Monopoly Rights model across India.